OP-5215

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameOP-5215
Drug Alias Namehomoharringtonine derivative (Oncopharm)OP-5215
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLeukemia, Myeloid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOncopharm Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOncopharm Corp
Active IndicationsN/A
Inactive IndicationsLeukemia, Myeloid

Other Information

ATC CodeN/A
Related LinksN/A